Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Agenus Inc. - Common Stock
(NQ:
AGEN
)
8.240
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Agenus Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Agenus (NASDAQ:AGEN) Passes Minervini Trend Template with High Growth Momentum
↗
August 27, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
July 14, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Monday?
↗
July 13, 2026
Via
Chartmill
Discover the most active stocks in Monday's session.
↗
July 13, 2026
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 13, 2026
Gainers Agenus (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session. The market value of their outstanding shares is at $139.5 million. Q32 Bio (NASDAQ:QTTB) stock rose...
Via
Benzinga
Top stock movements in today's session.
↗
July 13, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Examining the Future: Agenus's Earnings Outlook
↗
August 08, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
July 13, 2026
Via
Chartmill
Agenus Pivots to Phase 3 Colon Cancer Trial, Lines Up $340 Million Financing
↗
July 13, 2026
Agenus (NASDAQ:AGEN) said it is shifting its development focus and financial resources toward a Phase 3 registrational trial of neoadjuvant botensilimab plus balstilimab, known as BOT/BAL, in high-risk...
Via
MarketBeat
Wondering what's happening in today's pre-market session?
↗
July 13, 2026
Via
Chartmill
Agenus Annual Meeting: BOT/BAL Leads Cancer Drug Push as Balance Sheet Improves
↗
June 16, 2026
Agenus (NASDAQ:AGEN) told shareholders at its 2026 virtual annual meeting that it remains focused on advancing its botensilimab and balstilimab immunotherapy combination, known as BOT/BAL, while...
Via
MarketBeat
Agenus (AGEN) Q2 2025 Earnings Call Transcript
↗
January 27, 2026
Agenus (AGEN) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Thursday's session: top gainers and losers
↗
January 15, 2026
Via
Chartmill
Which stocks are moving on Thursday?
↗
January 15, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
January 15, 2026
Via
Chartmill
Agenus (AGEN) Q3 2024 Earnings Call Transcript
↗
January 05, 2026
Agenus (AGEN) Q3 2024 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Agenus (AGEN) Q1 2025 Earnings Call Transcript
↗
January 05, 2026
Agenus (AGEN) Q1 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Agenus (AGEN) Q4 2024 Earnings Call Transcript
↗
January 05, 2026
Agenus (AGEN) Q4 2024 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
AGENUS INC (NASDAQ:AGEN) Reports Mixed Q3 2025 Earnings, Driven by One-Time Gain
↗
November 10, 2025
Agenus reports mixed Q3 2025 results with a revenue miss but strong clinical progress for its cancer drug BOT/BAL, including a new Phase 3 trial.
Via
Chartmill
Insights Ahead: Agenus's Quarterly Earnings
↗
November 07, 2025
Via
Benzinga
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
November 06, 2025
San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....
Via
MarketMinute
Topics
Intellectual Property
Monday's pre-market session: top gainers and losers
↗
August 11, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Agenus Posts 48% Q2 Revenue Miss
↗
August 11, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 07, 2025
Via
Benzinga
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash Overhang
↗
June 04, 2025
Zydus acquires two Agenus biologics facilities in California for $75 million, expanding U.S. CDMO presence and securing rights to key cancer drug manufacturing.
Via
Benzinga
Agenus Stock Is Trading Higher Tuesday: What's Going On?
↗
June 03, 2025
Agenus announced it signed a partnership agreement with Zydus Lifesciences to expand patient access to Botensilimab and Balstilimab.
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
June 03, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 03, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
